CARIS LIFE SCIENCES, INC. vs LABCORP HOLDINGS INC., two Medical Diagnostics stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
The split here is simple: Labcorp is diagnostics as infrastructure, a national lab network earning a 10.8% operating margin with a 6.2% free-cash yield and a dividend at 24.1 times earnings; Caris is diagnostics as frontier, molecular tumor profiling at a 2.4% operating margin priced at 52.9 times. Labcorp carries acquisition debt, 0.73 turns; Caris carries IPO cash, a 7.05 current ratio. Returns on equity run 10.8% against 5.7%. The network's price asks for continuation and pays you cash while it continues; the frontier's price asks for transformation and pays nothing until it arrives. Both can deliver; only one has to.
Comparison updated 2026-07-10.
| Metric | CAI | LH |
|---|---|---|
| Price | $18.52 | $271.48 |
| Market cap | $5.2B | $22.5B |
| Sector | Medical Diagnostics | Medical Diagnostics |
| Stage | Growth | Mature |
| Implied growth (priced in) | — | -1.3% |
| P/E | 52.9 | 24.1 |
| P/B | 8.82 | 2.58 |
| P/S | 5.77 | 1.59 |
| EV/EBITDA | 37.2 | 17.3 |
| Revenue growth | +91.2% | +7.4% |
| Gross margin | — | 28.7% |
| Operating margin | 2.4% | 10.8% |
| Net margin | 3.8% | 6.7% |
| Return on equity | 5.7% | 10.8% |
| Return on assets | 2.9% | 4.9% |
| Return on invested capital | 8.8% | 7.5% |
| FCF yield | 2.4% | 6.2% |
| Dividend yield | — | 1.1% |
| Debt / equity | 0.64 | 0.73 |
| Current ratio | 7.05 | 1.73 |
| Altman Z (solvency) | 4.14 | 2.88 |
| Piotroski F (quality) | 5 / 9 | 4 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.